FILED AND SPONSOR-REPORTED ETF HOLDINGS
ERAS Included in ETFs
Dates are first observed in retained official snapshots; “baseline” means the security was already present in the earliest retained snapshot and is not an invented original addition date.
Current ETFs holding ERAS
6 latest ETF portfolios currently report this security.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| BBC | Virtus Biotech Clinical Trials Etf | 2.187024% | 2026-01-30 (baseline) | 2026-04-30 |
| CANC | Tema Oncology ETF | 1.448104% | 2026-02-28 | 2026-02-28 |
| LABU | Direxion Daily S&P Biotech Bull 3X Shares | 0.556615% | 2026-04-30 (baseline) | 2026-04-30 |
| STXK | Strive Small-Cap ETF | 0.2% | 2026-03-31 | 2026-03-31 |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.080351% | 2026-04-30 | 2026-04-30 |
| IWV | iShares Russell 3000 ETF | 0.004417% | 2025-12-31 (baseline) | 2026-03-31 |
Previous ETFs holding ERAS
No previous ETF membership has been observed within the retained snapshot history.